E P Magalong Jr Md Inc | |
1050 Marina Village Pkwy Ste 101 Alameda CA 94501-1033 | |
(510) 227-5540 | |
(510) 788-6849 |
Full Name | E P Magalong Jr Md Inc |
---|---|
Speciality | Internal Medicine |
Location | 1050 Marina Village Pkwy Ste 101, Alameda, California |
Authorized Official Name and Position | Elpidio Posa Magalong (PRESIDENT) |
Authorized Official Contact | 5102275540 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
E P Magalong Jr Md Inc 1050 Marina Village Pkwy Ste 101 Alameda CA 94501-1033 Ph: (510) 227-5540 | E P Magalong Jr Md Inc 1050 Marina Village Pkwy Ste 101 Alameda CA 94501-1033 Ph: (510) 227-5540 |
NPI Number | 1124787171 |
---|---|
Provider Enumeration Date | 12/16/2021 |
Last Update Date | 08/22/2022 |
Medicare PECOS PAC ID | 5294102604 |
---|---|
Medicare Enrollment ID | O20221027001713 |
News Archive
Benitec Limited (ASX:BLT), a company involved in RNA-based gene silencing for human therapeutics, announced that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec's DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Three children Alejandro Gutierrez, MD, treated for leukemia during his fellowship at Boston Children's Hospital still haunt him more than a decade later.
Oxford Gene Technology, The Molecular Genetics Company, has been speaking to genetic scientists, Dr Tracey Lewis (Associated Regional and University Pathologists Laboratories) and Dr Emily Farrow (Children's Mercy Hospital), in a new whitepaper entitled "Examining the Medical Exome".
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1124787171 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (* (Not Available)) | Primary |
Provider Name | Elpidio P Magalong |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1992773279 PECOS PAC ID: 2567464647 Enrollment ID: I20070201000560 |
News Archive
Benitec Limited (ASX:BLT), a company involved in RNA-based gene silencing for human therapeutics, announced that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec's DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Three children Alejandro Gutierrez, MD, treated for leukemia during his fellowship at Boston Children's Hospital still haunt him more than a decade later.
Oxford Gene Technology, The Molecular Genetics Company, has been speaking to genetic scientists, Dr Tracey Lewis (Associated Regional and University Pathologists Laboratories) and Dr Emily Farrow (Children's Mercy Hospital), in a new whitepaper entitled "Examining the Medical Exome".
› Verified 4 days ago
News Archive
Benitec Limited (ASX:BLT), a company involved in RNA-based gene silencing for human therapeutics, announced that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec's DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Three children Alejandro Gutierrez, MD, treated for leukemia during his fellowship at Boston Children's Hospital still haunt him more than a decade later.
Oxford Gene Technology, The Molecular Genetics Company, has been speaking to genetic scientists, Dr Tracey Lewis (Associated Regional and University Pathologists Laboratories) and Dr Emily Farrow (Children's Mercy Hospital), in a new whitepaper entitled "Examining the Medical Exome".
› Verified 4 days ago
Spherical Medical, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2070 Clinton Ave, Alameda, CA 94501 Phone: 510-814-4397 Fax: 510-265-1015 | |
Alameda Medical Professionals. Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 430 Willow Street, Alameda, CA 94501 Phone: 510-749-9817 Fax: 510-752-9094 | |
Affinity Health Advantage Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2217 S Shore Ctr # 250, Alameda, CA 94501 Phone: 510-323-4410 | |
Alameda Hospital Physicians - A Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 S Shore Ctr W, Suite A-f, Alameda, CA 94501 Phone: 510-814-4630 Fax: 510-814-4356 | |
Harbor Bay Chiropractic, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1151 Harbor Bay Pkwy, Suite 127, Alameda, CA 94502 Phone: 510-521-6211 Fax: 510-521-6214 | |
John Khade, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1406 Park St Ste 400, Alameda, CA 94501 Phone: 510-865-6000 |